Your browser doesn't support javascript.
loading
Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Yukitake, Motohiro; Sueoka, Eisaburo; Sueoka-Aragane, Naoko; Sato, Akemi; Ohashi, Hiromi; Yakushiji, Yusuke; Saito, Mineki; Osame, Mitsuhiro; Izumo, Shuji; Kuroda, Yasuo.
Afiliação
  • Yukitake M; Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan. yukitake@cc.saga-u.ac.jp
J Neurovirol ; 14(2): 130-5, 2008 Apr.
Article em En | MEDLINE | ID: mdl-18444084
It has been reported that antibodies (Abs) against heterogeneous nuclear ribonucleoproteins (hnRNPs) are associated with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS). However, these studies were done under nonmasked conditions. In order to determine whether Abs against hnRNPs associate with HAM/TSP and MS, the authors assayed Abs against two major hnRNPs, hnRNP A1 and A2/B1, in 105 cerebrospinal fluid (CSF) samples under fully masked conditions. Samples included 40 cases of HAM/TSP, 28 of MS, and 37 of other neurological diseases. Anti-hnRNP A1 Abs, and especially anti-hnRNP A2/B1 Abs, were found significantly more often in the CSF of MS patients than in other groups. However, there was no difference in the incidence of anti-hnRNP A1 Abs between HAM/TSP and other disease groups.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Ribonucleoproteínas Nucleares Heterogêneas / Esclerose Múltipla Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurovirol Assunto da revista: NEUROLOGIA / VIROLOGIA Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Ribonucleoproteínas Nucleares Heterogêneas / Esclerose Múltipla Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurovirol Assunto da revista: NEUROLOGIA / VIROLOGIA Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos